"GO.ID","Term","Annotated","Significant","Expected","Rank.in.p.value_classic","p.value_elim","p.value_classic","genes"
"GO:0030049","muscle filament sliding",39,6,0.06,1,1.1e-12,1.6e-11,"ACTA1,MYH2,MYH4,MYH7,MYL3,TNNC2"
"GO:0003008","system process",1696,12,2.48,7,0.0048,1.3e-06,"ACTA1,ATP2A1,GABRA3,KNG1,MEF2C,MYH1,MYH2,MYH4,MYH7,MYL3,OR2A4,TNNC2"
"GO:0003009","skeletal muscle contraction",41,3,0.06,9,0.02427,2.8e-05,"ATP2A1,MYH7,TNNC2"
"GO:0050881","musculoskeletal movement",51,3,0.07,11,0.0328,5.5e-05,"ATP2A1,MYH7,TNNC2"
"GO:0050879","multicellular organismal movement",51,3,0.07,12,0.0328,5.5e-05,"ATP2A1,MYH7,TNNC2"
"GO:0006937","regulation of muscle contraction",146,4,0.21,13,0.00589,5.6e-05,"ATP2A1,MYH7,MYL3,TNNC2"
"GO:0006941","striated muscle contraction",162,4,0.24,14,0.02283,8.4e-05,"ATP2A1,MYH7,MYL3,TNNC2"
"GO:0003208","cardiac ventricle morphogenesis",68,3,0.1,15,0.01915,0.00013,"MEF2C,MYH7,MYL3"
"GO:0014819","regulation of skeletal muscle contraction",13,2,0.02,16,7.2e-05,0.00016,"ATP2A1,MYH7"
"GO:0006942","regulation of striated muscle contraction",85,3,0.12,18,0.0613,0.00025,"ATP2A1,MYH7,MYL3"
"GO:0014898","cardiac muscle hypertrophy in response to stress",23,2,0.03,20,0.00023,0.00051,"MEF2C,MYH7"
"GO:0043501","skeletal muscle adaptation",25,2,0.04,23,0.00027,6e-04,"ACTA1,MYH7"
"GO:0003231","cardiac ventricle development",120,3,0.18,24,0.06306,0.00069,"MEF2C,MYH7,MYL3"
"GO:0002026","regulation of the force of heart contraction",28,2,0.04,26,0.00035,0.00076,"MYH7,MYL3"
"GO:0007519","skeletal muscle tissue development",157,3,0.23,28,0.00047,0.0015,"ACTA1,MEF2C,MYL3"
"GO:0055010","ventricular cardiac muscle tissue morphogenesis",46,2,0.07,33,0.00094,0.00203,"MYH7,MYL3"
"GO:0008015","blood circulation",448,4,0.65,37,0.03014,0.00378,"ATP2A1,KNG1,MYH7,MYL3"
"GO:0003013","circulatory system process",455,4,0.66,38,0.03139,0.00399,"ATP2A1,KNG1,MYH7,MYL3"
"GO:0030239","myofibril assembly",65,2,0.09,39,0.00186,0.00402,"ACTA1,MEF2C"
"GO:0030279","negative regulation of ossification",68,2,0.1,42,0.00203,0.00439,"LRP4,MEF2C"
"GO:0014902","myotube differentiation",96,2,0.14,52,0.004,0.00857,"ACTA1,MEF2C"
"GO:0090073","positive regulation of protein homodimerization activity",10,1,0.01,57,0.00988,0.0145,"MEF2C"
"GO:1904396","regulation of neuromuscular junction development",10,1,0.01,58,0.00988,0.0145,"LRP4"
"GO:0097105","presynaptic membrane assembly",10,1,0.01,59,0.00988,0.0145,"LRP4"
"GO:0051124","synaptic growth at neuromuscular junction",10,1,0.01,60,0.00988,0.0145,"LRP4"
"GO:1903909","regulation of receptor clustering",10,1,0.01,61,0.00988,0.0145,"LRP4"
"GO:0051561","positive regulation of mitochondrial calcium ion concentration",10,1,0.01,62,0.00988,0.0145,"ATP2A1"
"GO:0048703","embryonic viscerocranium morphogenesis",10,1,0.01,63,0.00988,0.0145,"MEF2C"
"GO:0060048","cardiac muscle contraction",128,2,0.19,64,0.007,0.01485,"MYH7,MYL3"
"GO:0060078","regulation of postsynaptic membrane potential",129,2,0.19,66,0.00711,0.01507,"GABRA3,MEF2C"
"GO:0071340","skeletal muscle acetylcholine-gated channel clustering",11,1,0.02,67,0.01087,0.01594,"LRP4"
"GO:0003207","cardiac chamber formation",11,1,0.02,68,0.01087,0.01594,"MEF2C"
"GO:0071888","macrophage apoptotic process",11,1,0.02,69,0.01087,0.01594,"MEF2C"
"GO:0051657","maintenance of organelle location",11,1,0.02,70,0.01087,0.01594,"ATP2A1"
"GO:0097104","postsynaptic membrane assembly",12,1,0.02,71,0.01185,0.01738,"LRP4"
"GO:1901626","regulation of postsynaptic membrane organization",13,1,0.02,73,0.01283,0.01881,"LRP4"
"GO:0045989","positive regulation of striated muscle contraction",13,1,0.02,74,0.01283,0.01881,"ATP2A1"
"GO:0007512","adult heart development",14,1,0.02,76,0.01381,0.02025,"MYH7"
"GO:0003128","heart field specification",14,1,0.02,77,0.01381,0.02025,"MEF2C"
"GO:0014733","regulation of skeletal muscle adaptation",14,1,0.02,78,0.01381,0.02025,"MYH7"
"GO:0072160","nephron tubule epithelial cell differentiation",14,1,0.02,79,0.01381,0.02025,"MEF2C"
"GO:0030240","skeletal muscle thin filament assembly",14,1,0.02,80,0.01381,0.02025,"ACTA1"
"GO:0042693","muscle cell fate commitment",15,1,0.02,81,0.01479,0.02168,"MEF2C"
"GO:0002467","germinal center formation",15,1,0.02,82,0.01479,0.02168,"MEF2C"
"GO:0014866","skeletal myofibril assembly",16,1,0.02,85,0.01577,0.02311,"ACTA1"
"GO:0055012","ventricular cardiac muscle cell differentiation",17,1,0.02,86,0.01675,0.02453,"MEF2C"
"GO:0001573","ganglioside metabolic process",17,1,0.02,87,0.01675,0.02453,"B3GALT4"
"GO:0007597","blood coagulation, intrinsic pathway",17,1,0.02,88,0.01675,0.02453,"KNG1"
"GO:0101023","vascular endothelial cell proliferation",18,1,0.03,89,0.01772,0.02596,"MEF2C"
"GO:1905562","regulation of vascular endothelial cell proliferation",18,1,0.03,90,0.01772,0.02596,"MEF2C"
"GO:0071498","cellular response to fluid shear stress",18,1,0.03,91,0.01772,0.02596,"MEF2C"
"GO:1904706","negative regulation of vascular smooth muscle cell proliferation",18,1,0.03,92,0.01772,0.02596,"MEF2C"
"GO:2000727","positive regulation of cardiac muscle cell differentiation",19,1,0.03,93,0.0187,0.02738,"MEF2C"
"GO:2001014","regulation of skeletal muscle cell differentiation",19,1,0.03,94,0.0187,0.02738,"MEF2C"
"GO:2000310","regulation of NMDA receptor activity",20,1,0.03,97,0.01967,0.0288,"MEF2C"
"GO:0048520","positive regulation of behavior",20,1,0.03,98,0.01967,0.0288,"MEF2C"
"GO:1904752","regulation of vascular associated smooth muscle cell migration",20,1,0.03,99,0.01967,0.0288,"MEF2C"
"GO:1904738","vascular associated smooth muscle cell migration",20,1,0.03,100,0.01967,0.0288,"MEF2C"
"GO:0030220","platelet formation",20,1,0.03,101,0.01967,0.0288,"MEF2C"
"GO:0014912","negative regulation of smooth muscle cell migration",21,1,0.03,102,0.02065,0.03022,"MEF2C"
"GO:0010226","response to lithium ion",21,1,0.03,103,0.02065,0.03022,"ACTA1"
"GO:0006925","inflammatory cell apoptotic process",21,1,0.03,104,0.02065,0.03022,"MEF2C"
"GO:0036344","platelet morphogenesis",21,1,0.03,105,0.02065,0.03022,"MEF2C"
"GO:0032469","endoplasmic reticulum calcium ion homeostasis",22,1,0.03,107,0.02162,0.03164,"ATP2A1"
"GO:0007214","gamma-aminobutyric acid signaling pathway",22,1,0.03,108,0.02162,0.03164,"GABRA3"
"GO:0030318","melanocyte differentiation",22,1,0.03,109,0.02162,0.03164,"MEF2C"
"GO:0045663","positive regulation of myoblast differentiation",22,1,0.03,110,0.02162,0.03164,"MEF2C"
"GO:2000311","regulation of AMPA receptor activity",23,1,0.03,111,0.02259,0.03305,"MEF2C"
"GO:0006688","glycosphingolipid biosynthetic process",23,1,0.03,112,0.02259,0.03305,"B3GALT4"
"GO:0060045","positive regulation of cardiac muscle cell proliferation",24,1,0.04,114,0.02356,0.03447,"MEF2C"
"GO:0015012","heparan sulfate proteoglycan biosynthetic process",25,1,0.04,116,0.02453,0.03588,"NDST4"
"GO:2000108","positive regulation of leukocyte apoptotic process",25,1,0.04,117,0.02453,0.03588,"MEF2C"
"GO:0090075","relaxation of muscle",26,1,0.04,118,0.0255,0.03729,"ATP2A1"
"GO:0048643","positive regulation of skeletal muscle tissue development",26,1,0.04,119,0.0255,0.03729,"MEF2C"
"GO:0036075","replacement ossification",26,1,0.04,120,0.0255,0.03729,"MEF2C"
"GO:0001958","endochondral ossification",26,1,0.04,121,0.0255,0.03729,"MEF2C"
"GO:0016358","dendrite development",212,2,0.31,123,0.01835,0.03795,"LRP4,MEF2C"
"GO:0072378","blood coagulation, fibrin clot formation",27,1,0.04,125,0.02647,0.03869,"KNG1"
"GO:0060536","cartilage morphogenesis",27,1,0.04,126,0.02647,0.03869,"MEF2C"
"GO:0042311","vasodilation",28,1,0.04,127,0.02744,0.0401,"KNG1"
"GO:1905209","positive regulation of cardiocyte differentiation",28,1,0.04,128,0.02744,0.0401,"MEF2C"
"GO:0033032","regulation of myeloid cell apoptotic process",28,1,0.04,129,0.02744,0.0401,"MEF2C"
"GO:0060914","heart formation",28,1,0.04,130,0.02744,0.0401,"MEF2C"
"GO:0032467","positive regulation of cytokinesis",29,1,0.04,131,0.02841,0.0415,"OR2A4"
"GO:0001782","B cell homeostasis",29,1,0.04,132,0.02841,0.0415,"MEF2C"
"GO:0002209","behavioral defense response",30,1,0.04,133,0.02937,0.0429,"MEF2C"
"GO:0001662","behavioral fear response",30,1,0.04,134,0.02937,0.0429,"MEF2C"
"GO:0009954","proximal/distal pattern formation",31,1,0.05,136,0.03034,0.0443,"LRP4"
"GO:0010092","specification of animal organ identity",31,1,0.05,137,0.03034,0.0443,"MEF2C"
"GO:0099068","postsynapse assembly",31,1,0.05,138,0.03034,0.0443,"LRP4"
"GO:0048741","skeletal muscle fiber development",31,1,0.05,139,0.03034,0.0443,"ACTA1"
"GO:0043537","negative regulation of blood vessel endothelial cell migration",31,1,0.05,140,0.03034,0.0443,"MEF2C"
"GO:0030201","heparan sulfate proteoglycan metabolic process",31,1,0.05,141,0.03034,0.0443,"NDST4"
"GO:0010922","positive regulation of phosphatase activity",32,1,0.05,142,0.0313,0.0457,"MEF2C"
"GO:0042596","fear response",32,1,0.05,143,0.0313,0.0457,"MEF2C"
"GO:0055023","positive regulation of cardiac muscle tissue growth",32,1,0.05,144,0.0313,0.0457,"MEF2C"
"GO:0033028","myeloid cell apoptotic process",32,1,0.05,145,0.0313,0.0457,"MEF2C"
"GO:0050931","pigment cell differentiation",32,1,0.05,146,0.0313,0.0457,"MEF2C"
"GO:0034405","response to fluid shear stress",33,1,0.05,147,0.03226,0.0471,"MEF2C"
"GO:0046034","ATP metabolic process",242,2,0.35,148,0.02351,0.04818,"MYH4,MYH7"
"GO:1903131","mononuclear cell differentiation",34,1,0.05,149,0.03323,0.04849,"MEF2C"
"GO:0014904","myotube cell development",34,1,0.05,150,0.03323,0.04849,"ACTA1"
"GO:2000725","regulation of cardiac muscle cell differentiation",34,1,0.05,151,0.03323,0.04849,"MEF2C"
"GO:0030224","monocyte differentiation",34,1,0.05,152,0.03323,0.04849,"MEF2C"
"GO:0030501","positive regulation of bone mineralization",34,1,0.05,153,0.03323,0.04849,"MEF2C"
"GO:0001937","negative regulation of endothelial cell proliferation",35,1,0.05,154,0.03419,0.04988,"MEF2C"
"GO:0060485","mesenchyme development",247,2,0.36,156,0.02442,0.04998,"ACTA1,MEF2C"
